MDxHealth is trading at $0.16, up 5.03% in pre-market on November 3, with no clear company-specific catalyst identified. - Recent after-hours trading was also higher, without a specific catalyst. - Q3 2026 results are scheduled for November 12. The October 15 preliminary revenue update and suspension of full-year guidance predate this move and are not confirmed explanations. - Broader market indicators are mixed, with no clear evidence overall sentiment is driving the move.